Gentamicin‐Loaded Chitosan Nanocoating on Polyurethane Prostatic Stents to Combat Biofilm Formation and Urogenital Device‐Associated Infections
Biotechnology and Applied Biochemistry · 2025
DOI: 10.1002/bab.70104 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biotechnology and Applied Biochemistry, 2025. Verfasst von Govindarajan Venkat Kumar und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemistry, SRM Institute of Science and Technology, Ramapuram Campus, Chennai, Tamil Nadu, India. Hauptthemen laut MEDLINE: Chitosan, Gentamicins, Biofilms, Anti-Bacterial Agents. Die Arbeit nennt 31 Literaturangaben.
Abstract (Originalsprache)
Prostatic obstruction is a blockage of the urethra caused by benign prostatic hyperplasia, a common condition in aging men that often results in significant urinary complications. Polyurethane prostatic stents are widely used to alleviate this obstruction. However, their susceptibility to biofilm formation and subsequent bacterial infections by pathogens such as Escherichia coli and Proteus mirabilis remains a major clinical challenge. This study investigates the polyurethane prostatic stents (PS) that are surface‐immobilized with gentamicin‐loaded chitosan nanoparticles (GMCSNPs) to combat these issues. GMCSNPs were synthesized via the ionic gelation method, achieving high drug encapsulation efficiency (92.32%) and exhibiting a spherical morphology, as confirmed by field emission scanning electron microscopy (FESEM); particle size was determined using a Zetasizer. The nanoparticles had a size range of 200–350 nm. The surface of polyurethane prostatic stents was activated and covalently immobilized with GMCSNPs, as confirmed through attenuated total reflection‐Fourier transform infrared spectroscopy (ATR‐FTIR) and FESEM analyses. The antimicrobial efficacy of GMCSNPs and GMCSNPs‐immobilized polyurethane prostatic stents (GMCSNPs‐PS) was evaluated against E. coli and P. mirabilis . Bacterial viability assays, flow cytometry, and biofilm inhibition studies revealed significant antibacterial activity and a marked reduction in biofilm formation. The sustained release of gentamicin, combined with the intrinsic antimicrobial properties of chitosan, demonstrated a synergistic effect, successfully inhibiting bacterial growth and biofilm development.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Chemistry, SRM Institute of Science and Technology, Ramapuram Campus, Chennai, Tamil Nadu, India.
- Chemistry Department, Faculty of Science, King Khalid University, Abha, Saudi Arabia.
- Department of Biotechnology, V.S.B. Engineering College, Karur, Tamil Nadu, India.
- Department of Biotechnology, SRM Arts and Science College, Kattankulathur, Tamil Nadu, India.
- Innovation and Incubation Centre for Health Sciences, Sree Balaji Medical College and Hospital, Bharath Institute of Higher Education and Research, Chennai, Tamil Nadu, India.
- Center for Global Health Research, Saveetha Medical College & Hospital, Saveetha Institute of Medical and Technical Sciences (SIMATS), Chennai, Tamil Nadu, India.
Zitieren
APA
Kumar, G. V., Bajaber, M. A., Mani, A. K., Jeyanthi, V., Velusamy, P., & Gopinath, S. C. B. (2025). Gentamicin‐Loaded Chitosan Nanocoating on Polyurethane Prostatic Stents to Combat Biofilm Formation and Urogenital Device‐Associated Infections. Biotechnology and Applied Biochemistry. https://doi.org/10.1002/bab.70104
Vancouver
Kumar GV, Bajaber MA, Mani AK, Jeyanthi V, Velusamy P, Gopinath SCB. Gentamicin‐Loaded Chitosan Nanocoating on Polyurethane Prostatic Stents to Combat Biofilm Formation and Urogenital Device‐Associated Infections. Biotechnology and Applied Biochemistry. 2025. doi:10.1002/bab.70104
BibTeX
@article{Kumar2025,
author = {Kumar, Govindarajan Venkat and Bajaber, Majed A and Mani, Anis Kumar and Jeyanthi, Venkadapathi and Velusamy, Palaniyandi and Gopinath, Subash C B},
title = {Gentamicin‐Loaded Chitosan Nanocoating on Polyurethane Prostatic Stents to Combat Biofilm Formation and Urogenital Device‐Associated Infections},
journal = {Biotechnology and Applied Biochemistry},
year = {2025},
doi = {10.1002/bab.70104}
}
EUVIMED